DrugPatentWatch Database Preview
US Patents With Foreign Priority to Patent: 08009260
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi-aventis Us | ADLYXIN | lixisenatide | SOLUTION;SUBCUTANEOUS | 208471-001 | Jul 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
Sanofi-aventis Us | ADLYXIN | lixisenatide | SOLUTION;SUBCUTANEOUS | 208471-002 | Jul 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |